Search by Drug Name or NDC
NDC 00121-0676-16 Potassium Citrate and Citric Acid 334; 1100 mg/5mL; mg/5mL Details
Potassium Citrate and Citric Acid 334; 1100 mg/5mL; mg/5mL
Potassium Citrate and Citric Acid is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PAI Holdings, LLC. The primary component is CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE.
Product Information
| NDC | 00121-0676 |
|---|---|
| Product ID | 0121-0676_16ac3c3c-e9a4-454b-9d37-3733b7af84fa |
| Associated GPIs | 56202022002025 |
| GCN Sequence Number | 048607 |
| GCN Sequence Number Description | potassium citrate/citric acid SOLUTION 1100-334/5 ORAL |
| HIC3 | R1S |
| HIC3 Description | URINARY PH MODIFIERS |
| GCN | 14065 |
| HICL Sequence Number | 003680 |
| HICL Sequence Number Description | POTASSIUM CITRATE/CITRIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Citrate and Citric Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Potassium Citrate and Citric Acid Monohydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 334; 1100 |
| Active Ingredient Units | mg/5mL; mg/5mL |
| Substance Name | CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE |
| Labeler Name | PAI Holdings, LLC |
| Pharmaceutical Class | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation F |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00121-0676-16 (00121067616)
| NDC Package Code | 0121-0676-16 |
|---|---|
| Billing NDC | 00121067616 |
| Package | 473 mL in 1 BOTTLE (0121-0676-16) |
| Marketing Start Date | 1997-10-07 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06531 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | POTASSIUM CIT-CITRIC ACID SOLN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis